Accuray (ARAY) Cash from Discontinued Operations (2012)
Accuray's (ARAY) quarterly Cash from Discontinued Operations came in at 4842000.0 in Q4 2012.
Accuray (ARAY) Cash from Discontinued Operations (2012) Analysis & Trends
Accuray's Cash from Discontinued Operations history runs 1 years deep, the most recent figure standing at 4842000.0 for Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | - |
| 10 | Accuray | 29,112.00 | -38.50 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -4.84 Mn |
| Dec 31, 2012 | -4.84 Mn |